EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 340 filers reported holding EXELIXIS INC in Q2 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,718,511 | +11.3% | 124,417 | -2.7% | 0.12% | +12.6% |
| Q2 2023 | $2,442,774 | -11.0% | 127,827 | -9.6% | 0.10% | -12.7% |
| Q1 2023 | $2,744,244 | -71.6% | 141,383 | -76.5% | 0.12% | -73.2% |
| Q4 2022 | $9,669,602 | +9.9% | 602,843 | +7.4% | 0.44% | -0.5% |
| Q3 2022 | $8,798,000 | -24.9% | 561,121 | -0.3% | 0.44% | -15.1% |
| Q2 2022 | $11,722,000 | -12.0% | 562,993 | -4.1% | 0.52% | +4.2% |
| Q1 2022 | $13,313,000 | +30.3% | 587,264 | +5.0% | 0.50% | +42.7% |
| Q4 2021 | $10,221,000 | -21.7% | 559,121 | -9.4% | 0.35% | -21.5% |
| Q3 2021 | $13,050,000 | +15.5% | 617,306 | -0.5% | 0.45% | +23.1% |
| Q2 2021 | $11,301,000 | -0.9% | 620,245 | +22.9% | 0.36% | -8.6% |
| Q1 2021 | $11,404,000 | +27.6% | 504,812 | +13.3% | 0.40% | +13.8% |
| Q4 2020 | $8,938,000 | +11.3% | 445,362 | +35.6% | 0.35% | -4.6% |
| Q3 2020 | $8,032,000 | +257.5% | 328,500 | +247.1% | 0.37% | +255.3% |
| Q2 2020 | $2,247,000 | +35.7% | 94,636 | -1.6% | 0.10% | +24.1% |
| Q1 2020 | $1,656,000 | – | 96,169 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |